88 Epizód

  1. Tim Vanuytsel on spore-forming probiotics in functional dyspepsia

    Közzétéve: 2021. 09. 09.

  2. Raymond Henderson on the economic burden of colorectal cancer

    Közzétéve: 2021. 08. 12.

  3. Sigurður Ólafsson on eliminating hepatitis C in Iceland

    Közzétéve: 2021. 06. 22.

  4. Caroline Ovadia on intrahepatic cholestasis of pregnancy

    Közzétéve: 2021. 06. 03.

  5. Matthew Akiyama on hepatitis C in prisons

    Közzétéve: 2021. 04. 12.

  6. Monika Sarkar on reproductive health in women with liver disease

    Közzétéve: 2021. 03. 11.

  7. Colorectal cancer risk in patients with Crohn’s disease

    Közzétéve: 2020. 03. 12.

  8. Liver damage in young adults

    Közzétéve: 2020. 01. 17.

  9. Treatments for IBS

    Közzétéve: 2020. 01. 14.

  10. Statins and decompensated cirrhosis

    Közzétéve: 2019. 11. 27.

  11. Global burden of pancreatic cancer and colorectal cancer

    Közzétéve: 2019. 11. 04.

  12. Paediatric inflammatory bowel disease

    Közzétéve: 2019. 09. 12.

  13. Transplanting hepatitis C-infected hearts

    Közzétéve: 2019. 08. 28.

  14. Primary anastomosis as a treatment for diverticulitis

    Közzétéve: 2019. 07. 31.

  15. Faecal microbiota transplantation in IBS

    Közzétéve: 2019. 07. 30.

  16. Treating faecal incontinence in women

    Közzétéve: 2019. 07. 17.

  17. Viral hepatitis in children & adolescents

    Közzétéve: 2019. 05. 23.

  18. Whole-body MRI: the STREAMLINE trials

    Közzétéve: 2019. 05. 11.

  19. A new drug for short bowel syndrome

    Közzétéve: 2019. 04. 05.

  20. Eosinophilic oesophagitis endotype classification

    Közzétéve: 2019. 03. 09.

3 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Visit the podcast's native language site